MOR (95%CI) | Model 0 | Model 1 | Model 2 | |||
---|---|---|---|---|---|---|
 | - | Age, gender | Age, gender, SES, ethnicity and urbanization level | |||
 | Network | Practice | Network | Practice | Network | Practice |
Gastrointestinal tract infection | 1.47 | 1.54 | 1.45 | 1.51 | 1.40 | 1.47 |
 | 1.22-2.75 | 1.40-1.68 | 1.21-2.66 | 1.38-1.64 | 1.17-2.50 | 1.36-1.61 |
Diabetes mellitus | 1.00 | 1.59 | 1.00 | 1.62 | 1.00 | 1.67 |
 | 1.00-1.37 | 1.44-1.77 | 1.00-1.42 | 1.46-1.81 | 1.00-1.49 | 1.48-1.87 |
Depression | 1.49 | 1.40 | 1.48 | 1.41 | 1.40 | 1.41 |
 | 1.14-3.04 | 1.29-1.52 | 1.12-3.02 | 1.31-1.54 | 1.00-2.77 | 1.30-1.55 |
Anxiety disorder | 1.71 | 1.52 | 1.70 | 1.51 | 1.63 | 1.52 |
 | 1.22-4.26 | 1.39-1.67 | 1.21-4.21 | 1.38-1.66 | 1.18-3.86 | 1.39-1.67 |
Stroke | 1.38 | 1.47 | 1.27 | 1.40 | 1.24 | 1.38 |
 | 1.10-2.49 | 1.33-1.65 | 1.03-2.08 | 1.30-1.56 | 1.00-2.02 | 1.29-1.40 |
CHD | 1.00 | 1.71 | 1.00 | 1.66 | -* | -* |
 | 1.00-1.86 | 1.51-1.95 | 1.00-1.50 | 1.48-1.89 |  |  |
COPD | 1.40 | 1.54 | 1.40 | 1.49 | 1.44 | 1.42 |
 | 1.09-2.87 | 1.39-1.73 | 1.12-2.76 | 1.35-1.66 | 1.17-2.78 | 1.30-1.60 |
Asthma | 1.37 | 1.70 | 1.38 | 1.69 | 1.43 | 1.70 |
 | 1.10-2.61 | 1.52-1.90 | 1.11-2.66 | 1.51-1.88 | 1.14-2.77 | 1.52-1.91 |
Urinary tract infection | 1.19 | 1.35 | 1.19 | 1.35 | 1.19 | 1.33 |
 | 1.00-1.69 | 1.27-1.49 | 1.00-1.70 | 1.27-1.44 | 1.00-1.68 | 1.25-1.42 |
Dermatitis | 1.20 | 1.28 | 1.19 | 1.27 | 1.19 | 1.26 |
 | 1.05-1.70 | 1.21-1.38 | 1.04-1.68 | 1.21-1.38 | 1.00-1.67 | 1.20-1.36 |
Osteoarthritis | 1.20 | 1.51 | -* | -* | -* | -* |
 | 1.00-1.87 | 1.37-1.65 |  |  |  |  |
Neck and back problems | 1.28 | 1.24 | 1.28 | 1.25 | 1.22 | 1.22 |
 | 1.13-1.94 | 1.19-1.33 | 1.13-1.94 | 1.19-1.35 | 1.07-1.74 | 1.17-1.31 |
Herpes zoster | 1.08 | 1.23 | 1.07 | 1.17 | 1.00 | 1.20 |
 | 1.00-1.34 | 1.11-1.36 | 1.00-1.29 | 1.00-1.31 | 1.00-1.26 | 1.06-1.34 |